Citalopram hydrobromide
CAS NO.59729-32-7
M.F:C20H22BrFN2O
M.W:405.3
Appearance:white crystalline powder
Purity:>99%
Used for APIs
The detailed specifications are as below:
| Itemoftesting | InspectionStandard |
| Appearance | Whitetoalmostwhitecrystallinepowder |
| Completenessofsolution | NMT0.040 |
| Identification:InfraredAbsorption | ConformstospectrumofCitalopramhydrobromideRS |
| Identification:HPLC | TheretentiontimeofthemajorpeakofsamplesolutionconformstothatofCitalopramhydrobromideRS |
| Identification:Bromide | ItrespondstothetestsforBromide |
| Specificrotation | Between-0.2°~+0.2°(at20°C) |
| PH | Between5.5-6.5 |
| Water | NMT0.5% |
| Residueonignition | NMT0.1% |
| Heavymetals | NMT0.002% |
| Residualsolvents | AcetoneNMT0.5% |
| TolueneNMT0.089% | |
| EthanolNMT0.5% | |
| AceticacidNMT0.5% | |
| 2-MethyltetrahydrofuranNMT0.0002% | |
| BenzeneNMT0.0002% | |
| Relatedsubstances | RelatedCompoundANMT0.10% |
| RelatedCompoundBNMT0.10% | |
| RelatedCompoundCNMT0.10% | |
| RelatedCompoundDNMT0.10% | |
| RelatedCompoundENMT0.10% | |
| SingleunknownimpurityNMT0.1% | |
| 1-(3-Dimethylaminopropyl)-1-(4`-fluorophenyl)-5-(4-dimethylaminobutyryl)-1,3-dihydrobenzonitrileNMT0.10% | |
| 4-[4-Dimethylamino)-1-(4`-fluorophenyl)-1-hydroxy-1-butyl]-3-hydroxymrthylbenzonitrileNMT0.10% | |
| TotalimpuritiesNMT0.5% | |
| Assay(ontheanhydrousbasis) | 98.0~102.0% |